"World's Most Complete Market Research Reports Repository"

Global Opioids Agonist Drugs Market, Forecast Till 2025

  • Category : Healthcare & Pharma
  • |
  • ID : 598430
  • |
  • Publishe Date : August 2018
  • |
  • No of Pages: 121
  • |
  • Publisher : Intellectual Research Partners

The Global Opioids Agonist Drugs Market is expected to grow USD XX Million by 2025 at a CAGR of around XX % during the forecast period, 2018-2025. Opioids are generally prescribed for treating pain. The opioid drug class includes oxycodone, heroin, codeine, morphine, morphine, hydrocodone, fentanyl, and methadone. It is also used as a cough suppressant and in diarrhea treatment.

Global opioids agonist drugs market is mainly driven by prevalence of chronic pain. According to a study published in the British Medical Journal, more than half of the population in the UK suffers from chronic pain. Moreover, growing prevalence of pain, cough and, diarrhea are the key factors expected to propel the demand for opioids agonist drugs within the forecast period. However, increasing use of cannabis over opioids agonist drugs may hamper the market growth.

By product, the market can be segmented into codeine, fentanyl, meperidine, methadone, morphine and others. In terms of revenue, morphine and codeine segments collectively accounted for largets share of the overall market in 2017. Uncontrolled prescription and development of opioid tolerance towards codeine and morphine would raise the demand through 2025. By application, the market is segmented based on pain management, cough treatment and diarrhea treatment. pain management is expected to show significant growth within the forecast period.

In terms of revene, North America held large chunk of market share in 2017. This is owing to availability of proper healthcare infrastructure. Asia Pacific is expected to witness fastest growth within the forecast period on account of increasing geriatric population base, coupled with increasing focus on palliative care

Key players operating in the global Opioids Agonist Drugs market are Pfizer, Inc., Purdue Pharma L.P., West-Ward Pharmaceuticals Corporation, Allergan, Janssen Pharmaceuticals, Inc., Egalet Corporation, Sun Pharmaceutical Industries Limited and others
?
Key Benefits of the Report:
? Global, Regional, Country, Application, and Deployment Market Size and Forecast from 2014-2025
? Detailed market dynamics, industry outlook with market specific PESTLE, Value Chain, Supply Chain, and SWOT Analysis to better understand the market and build strategies
? Identification of key companies that can influence this market on a global and regional scale
? Expert interviews and their insights on market shift, current and future outlook and factors impacting vendors short term and long term strategies
? Detailed insights on emerging regions, deployment & application, and competitive landscape with qualitative and quantitative information and facts

TABLE OF CONTENT
1 EXECUTIVE SUMMARY

2 METHODOLOGY AND MARKET SCOPE
2.1 Research Methodology
2.2 Research Scope & Assumptions

3 OPIOIDS AGONIST DRUGS MARKET ? INDUSTRY OUTLOOK
3.1 Market Segmentation and Scope
3.2 Market Size & Growth Prospects
3.3 Opioids Agonist Drugs Market ? Value Chain / Supply Chain Analysis
3.3.1 Company Landscape
3.4 Opioids Agonist Drugs Market ? Market Dynamics
3.4.1 Market Driver
3.4.2 Market Restraints
3.4.3 Market Challenges
3.5 Opioids Agonist Drugs Market Company Market Share, 2017
3.6 Opioids Agonist Drugs Market ? Porter?s Five Forces Analysis
3.7 Opioids Agonist Drugs Market ? Pestel Analysis

4 OPIOIDS AGONIST DRUGS MARKET TYPE OUTLOOK
4.1 Opioids Agonist Drugs Market Share By Application, 2016 & 2025
4.2 Codeine
4.3 Fentanyl
4.4 Meperidine
4.5 Methadone
4.6 Morphine
4.7 Hydrocodone

5 OPIOIDS AGONIST DRUGS MARKET APPLICATION OUTLOOK
5.1 Opioids Agonist Drugs Market Share By Application, 2016 & 2025
5.2 Pain Managementq
5.3 Cough Treatment
5.4 Diarrhea Treatment

6 OPIOIDS AGONIST DRUGS MARKET REGIONAL OUTLOOK
6.1 Opioids Agonist Drugs Market Share by Region, 2016 & 2025
6.2 North America
6.2.1 North America Opioids Agonist Drugs Market, 2014 - 2025
6.2.2 North America Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.2.3 North America Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.2.5 U.S.
6.2.5.1 U.S. Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.2.5.2 U.S. Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.2.6 Canada
6.2.6.1 Canada Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.2.6.2 Canada Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.3 Europe
6.3.1 Europe Opioids Agonist Drugs Market, 2014 ? 2025
6.3.2 Europe Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.3.3 Europe Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.3.5 Germany
6.3.5.1 Germany Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.3.5.2 Germany Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.3.6 UK
6.3.6.1 UK Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.3.6.2 UK Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.4 Asia Pacific
6.4.1 Asia Pacific Opioids Agonist Drugs Market, 2014 - 2025
6.4.2 Asia Pacific Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.4.3 Asia Pacific Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.4.5 Australia
6.4.5.1 Australia Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.4.5.2 Australia Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.4.6 New Zealand
6.4.6.1 New Zealand Opioids Agonist Drugs Market, By Type, 2014 -
2025
6.4.6.2 New Zealand Opioids Agonist Drugs Market, By Application, 2014 -2025
6.4.6.3 New Zealand Opioids Agonist Drugs Market, By End-Use, 2014 -2025
6.4.7 China
6.4.7.1 China Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.4.7.2 China Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.4.8 India
6.4.8.1 India Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.4.8.2 India Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.4.9 Japan
6.4.9.1 Japan Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.4.9.2 Japan Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.5 Latin America
6.5.1 Latin America Opioids Agonist Drugs Market, 2014 - 2025
6.5.2 Latin America Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.5.3 Latin America Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.5.5 Brazil
6.5.5.1 Brazil Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.5.5.2 Brazil Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.5.6 Mexico
6.5.6.1 Mexico Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.5.6.2 Mexico Opioids Agonist Drugs Market, By Application, 2014 - 2025
6.6 MEA
6.6.1 MEA Opioids Agonist Drugs Market, 2014 - 2025
6.6.2 MEA Opioids Agonist Drugs Market, By Type, 2014 - 2025
6.6.3 MEA Opioids Agonist Drugs Market, By Application, 2014 - 2025
?
7 COMPETITIVE LANDSCAPE
7.1 Purdue Pharma
7.1.1 Company overview
7.1.2 Financial performance
7.1.3 Product benchmarking
7.1.4 Strategic initiatives
7.2 Pfizer Inc
7.2.1 Company overview
7.2.2 Financial performance
7.2.3 Product benchmarking
7.2.4 Strategic initiatives
7.3 Egalet Corporation
7.3.1 Company overview
7.3.2 Financial performance
7.3.3 Product benchmarking
7.3.4 Strategic initiatives
7.4 Janssen Pharmaceuticals, Inc
7.4.1 Company overview
7.4.2 Financial performance
7.4.3 Product benchmarking
7.4.4 Strategic initiatives
7.5 Allergan, Plc
7.5.1 Company overview
7.5.2 Financial performance
7.5.3 Product benchmarking
7.5.4 Strategic initiatives
7.6 Egalet Corporation
7.6.1 Company overview
7.6.2 Financial performance
7.6.3 Product benchmarking
7.6.4 Strategic initiatives

Content are not available

Choose License Type